Trial Profile

A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Investigate the Safety, Tolerability, and Efficacy of JBT-101 in Subjects With Dermatomyositis

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 23 Jan 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Oct 2022 Results published in the Journal of Investigative Dermatology
04 Jun 2022 Results of retrospective analysis of this study assessing the correlations between CDASI-A, quality of life (QoL), and biomarkers of disease activity, presented at the 23rd Annual Congress of the European League Against Rheumatism.
05 Jun 2021 Results assessing long-term safety and efficacy in Dermatomyositis subjects presented at the 22nd Annual Congress of the European League Against Rheumatism

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com